United Kingdom· GB-APID-14490111000001101
Megace 160mg tablets
A medicinal product containing megestrol, registered in United Kingdom by Sigma Pharmaceuticals Plc.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Megestrol
- Manufacturer
- Sigma Pharmaceuticals Plc
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Megestrol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- IrelandMegace 160 mg tabletsPCO Manufacturing Ltd.
- NorwayMegaceBausch Health Ireland Limited
- SpainBOREA 160 mg COMPRIMIDOSViatris Healthcare Limited
- SwedenMegace 160 mg TablettBausch Health Ireland Ltd
- FinlandMegaceBristol-Myers Squibb Ab
- FranceMEGACE 160 mg, compriméBAUSCH HEALTH IRELAND (IRLANDE)
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Poland · Cachexan, Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97a6d008-5eb7-4f10-9523-275b7f2ea152 GET /v1/drugs/97a6d008-5eb7-4f10-9523-275b7f2ea152?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "14490111000001101",
"desc": "Megace 160mg tablets (Sigma Pharmaceuticals Plc)",
"form": "Oral tablet",
"vpid": "41879711000001101",
"source": "dmd",
"vtm_id": "776657002",
"strength": "160 mg",
"substance": "Megestrol",
"ingredient": "Megestrol acetate",
"supplier_code": "2087601000001106"
}See everything about megestrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.